Pharmaceuticals, Biotechnology and Life Sciences
Industry leaders partner to help life sciences companies compliantly manage global events PLEASANTON, Calif. & TYSONS, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/VeevaSummit?src=hash" target="_blank"gt;#VeevaSummitlt;/agt;–Veeva…
AUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics Inc. (Triumvira), a privately held biopharmaceutical company developing a novel platform for engineering…
BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months ended March 31, 2019. On…
First-quarter revenue $2,684 million and Adjusted EBITDA $587 million GAAP Diluted Earnings per Share $0.29; Adjusted Diluted Earnings per Share…
Conference call scheduled today at 9:00 a.m. ET BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24ARQL&src=ctag" target="_blank"gt;$ARQLlt;/agt; lt;a href="https://twitter.com/hashtag/arql?src=hash" target="_blank"gt;#arqllt;/agt;–ArQule, Inc. (Nasdaq: ARQL) today…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Optivida will leverage Frelii’s proprietary DNAKit Packages™ to ensure Optivida customers can realize the optimalbenefits of which specific Optivida products best suit their unique DNAprofile.
Clinical trial agreements are one of the most important agreements inthe pharma industry as no research can start without the right agreementin place between sponsor and host organisation.
Noble unveiled today a new injectiontraining platform based on 1 mL and 2.25 mL YpsoMate devices to helpimprove patient onboarding and health outcomes.
Mission Therapeutics today announced the appointment of Dr. James Summers asan independent member to its Board of Directors, with immediate effect.